We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEON.WS
2026
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$978K ﹤0.01%
100,330
FSRX
2027
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$976K ﹤0.01%
100,284
+300
+0.3% +$2.91K
IEUR icon
2028
iShares Core MSCI Europe ETF
IEUR
$8.82B
$975K ﹤0.01%
+17,388
New +$1.01M
GRCL
2029
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$975K ﹤0.01%
70,306
-4,728
-6% -$55.8K
PAQCW
2030
CALL
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$975K ﹤0.01%
99,997
AMG icon
2031
Affiliated Managers Group
AMG
$9.78B
$972K ﹤0.01%
6,434
-28,072
-81% -$4.6M
GORO icon
2032
Goldgroup Mining Inc.
GORO
$152M
$972K ﹤0.01%
619,000
+326,266
+111% +$620K
KBE icon
2033
CALL
State Street SPDR S&P Bank ETF
KBE
$1.66B
$968K ﹤0.01%
18,300
NEUE
2034
DELISTED
NeueHealth
NEUE
$965K ﹤0.01%
+1,478
New +$1.3M
POWW icon
2035
Outdoor Holding Co
POWW
$256M
$963K ﹤0.01%
+156,641
New +$1.13M
HSBC icon
2036
HSBC
HSBC
$356B
$962K ﹤0.01%
36,805
-91,169
-71% -$2.48M
GM icon
2037
General Motors
GM
$81.7B
$961K ﹤0.01%
18,232
-11,537
-39% -$613K
NDACW
2038
CALL
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$960K ﹤0.01%
98,311
STXS icon
2039
Stereotaxis
STXS
$128M
$959K ﹤0.01%
+178,183
New +$1.34M
OTMOW
2040
CALL
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$956K ﹤0.01%
+200,000
New +$194K
OTECW
2041
CALL
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$953K ﹤0.01%
+96,500
New +$48.3K
SCVX.WS
2042
CALL
DELISTED
SCVX Corp.
SCVX.WS
$953K ﹤0.01%
+96,006
New +$86K
CWBC
2043
Community West Bancshares
CWBC
$693M
$951K ﹤0.01%
44,224
+10,581
+31% +$228K
EVR icon
2044
Evercore
EVR
$13.2B
$947K ﹤0.01%
7,084
-600
-8% -$81.5K
WNS
2045
DELISTED
WNS Holdings
WNS
$947K ﹤0.01%
11,574
-29,416
-72% -$2.4M
TCRT icon
2046
Alaunos Therapeutics
TCRT
$4.64M
$944K ﹤0.01%
+3,459
New +$1.06M
NABL icon
2047
N-able
NABL
$818M
$941K ﹤0.01%
+75,836
New +$1.04M
VIA
2048
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$941K ﹤0.01%
+18,465
New +$1.02M
HELE icon
2049
Helen of Troy
HELE
$672M
$939K ﹤0.01%
4,180
-4,237
-50% -$970K
USIO icon
2050
Usio Inc
USIO
$53.8M
$939K ﹤0.01%
158,598
-20,582
-11% -$120K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.